Microbiota as Predictor of Mortality in Allogeneic Hematopoietic-Cell Transplantation

被引:496
作者
Peled, Jonathan U. [1 ,6 ]
Gomes, Antonio L. C. [4 ]
Devlin, Sean M. [3 ]
Littmann, Eric R. [4 ,7 ]
Taur, Ying [2 ,6 ]
Sung, Anthony D. [8 ]
Weber, Daniela [11 ,12 ]
Hashimoto, Daigo [14 ]
Slingerland, Ann E. [4 ]
Slingerland, John B. [4 ]
Maloy, Molly [1 ]
Clurman, Annelie G. [1 ]
Stein-Thoeringer, Christoph K. [4 ]
Markey, Kate A. [1 ,6 ]
Docampo, Melissa D. [4 ,6 ]
Burgos da Silva, Marina [4 ]
Khan, Niloufer [1 ]
Gessner, Andre [12 ,13 ]
Messina, Julia A. [9 ]
Romero, Kristi [10 ]
Lew, Meagan V. [8 ]
Bush, Amy [8 ]
Bohannon, Lauren [8 ]
Brereton, Daniel G. [1 ]
Fontana, Emily [2 ]
Amoretti, Luigi A. [2 ]
Wright, Roberta J. [2 ]
Armijo, Gabriel K. [4 ]
Shono, Yusuke [4 ]
Sanchez-Escamilla, Miriam [1 ,16 ]
Castillo Flores, Nerea [1 ]
Alarcon Tomas, Ana [1 ,18 ]
Lin, Richard J. [1 ,6 ]
Yanez San Segundo, Lucrecia [1 ,17 ]
Shah, Gunjan L. [1 ,6 ]
Cho, Christina [1 ,6 ]
Scordo, Michael [1 ,6 ]
Politikos, Ioannis [1 ,6 ]
Hayasaka, Kasumi [15 ]
Hasegawa, Yuta [14 ]
Gyurkocza, Boglarka [1 ,6 ]
Ponce, Doris M. [1 ,6 ]
Barker, Juliet N. [1 ,6 ]
Perales, Miguel-Angel [1 ,6 ]
Giralt, Sergio A. [1 ,6 ]
Jenq, Robert R. [19 ,20 ]
Teshima, Takanori [14 ,15 ]
Chao, Nelson J. [8 ]
Holler, Ernst [11 ,12 ]
Xavier, Joao B. [5 ]
机构
[1] Mem Sloan Kettering Canc Ctr, Adult Bone Marrow Transplantat Serv, 1275 York Ave, New York, NY 10021 USA
[2] Mem Sloan Kettering Canc Ctr, Infect Dis Serv, New York, NY 10021 USA
[3] Mem Sloan Kettering Canc Ctr, Dept Med, Dept Epidemiol & Biostat, 1275 York Ave, New York, NY 10021 USA
[4] Mem Sloan Kettering Canc Ctr, Dept Immunol, Sloan Kettering Inst, New York, NY 10021 USA
[5] Mem Sloan Kettering Canc Ctr, Program Computat & Syst Biol, 1275 York Ave, New York, NY 10021 USA
[6] Weill Cornell Med Coll, Dept Med, New York, NY USA
[7] Univ Chicago, Duchossois Family Inst, Chicago, IL 60637 USA
[8] Duke Univ, Med Ctr, Dept Med, Div Hematol Malignancies & Cellular Therapy, Durham, NC 27710 USA
[9] Duke Univ, Dept Med, Div Infect Dis, Durham, NC USA
[10] Duke Univ, Sch Med, Duke Off Clin Res, Durham, NC USA
[11] Univ Med Ctr, Dept Hematol & Oncol, Internal Med 3, Regensburg, Germany
[12] Collaborat Res Ctr Transregio 221, Regensburg, Germany
[13] Univ Hosp Regensburg, Inst Clin Microbiol & Hyg, Regensburg, Germany
[14] Hokkaido Univ, Fac Med, Dept Hematol, Sapporo, Hokkaido, Japan
[15] Hokkaido Univ Hosp, Div Lab & Transfus Med, Sapporo, Hokkaido, Japan
[16] Res Inst Marques de Valdecilla IDIVAL, Santander, Spain
[17] Univ Cantabria, Dept Hematol, Hosp Univ Marques de Valdecilla IDIVAL, Santander, Spain
[18] Hosp Univ Puerta de Hierro, Madrid, Spain
[19] Univ Texas MD Anderson Canc Ctr, Dept Genom Med, Div Canc Med, Houston, TX 77030 USA
[20] Univ Texas MD Anderson Canc Ctr, Dept Stem Cell Transplantat Cellular Therapy, Div Canc Med, Houston, TX 77030 USA
基金
美国国家卫生研究院; 日本科学技术振兴机构; 日本学术振兴会;
关键词
INTESTINAL MICROBIOTA; HOST-DISEASE; DIVERSITY; RISK; COLONIZATION; ANTIBIOTICS; DOMINATION;
D O I
10.1056/NEJMoa1900623
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
In this study, the gastrointestinal microbiome was serially monitored in patients undergoing allogeneic hematopoietic-cell transplantation at four centers. Lower microbial diversity was associated with poorer outcomes after HCT. Background Relationships between microbiota composition and clinical outcomes after allogeneic hematopoietic-cell transplantation have been described in single-center studies. Geographic variations in the composition of human microbial communities and differences in clinical practices across institutions raise the question of whether these associations are generalizable. Methods The microbiota composition of fecal samples obtained from patients who were undergoing allogeneic hematopoietic-cell transplantation at four centers was profiled by means of 16S ribosomal RNA gene sequencing. In an observational study, we examined associations between microbiota diversity and mortality using Cox proportional-hazards analysis. For stratification of the cohorts into higher- and lower-diversity groups, the median diversity value that was observed at the study center in New York was used. In the analysis of independent cohorts, the New York center was cohort 1, and three centers in Germany, Japan, and North Carolina composed cohort 2. Cohort 1 and subgroups within it were analyzed for additional outcomes, including transplantation-related death. Results We profiled 8767 fecal samples obtained from 1362 patients undergoing allogeneic hematopoietic-cell transplantation at the four centers. We observed patterns of microbiota disruption characterized by loss of diversity and domination by single taxa. Higher diversity of intestinal microbiota was associated with a lower risk of death in independent cohorts (cohort 1: 104 deaths among 354 patients in the higher-diversity group vs. 136 deaths among 350 patients in the lower-diversity group; adjusted hazard ratio, 0.71; 95% confidence interval [CI], 0.55 to 0.92; cohort 2: 18 deaths among 87 patients in the higher-diversity group vs. 35 deaths among 92 patients in the lower-diversity group; adjusted hazard ratio, 0.49; 95% CI, 0.27 to 0.90). Subgroup analyses identified an association between lower intestinal diversity and higher risks of transplantation-related death and death attributable to graft-versus-host disease. Baseline samples obtained before transplantation already showed evidence of microbiome disruption, and lower diversity before transplantation was associated with poor survival. Conclusions Patterns of microbiota disruption during allogeneic hematopoietic-cell transplantation were similar across transplantation centers and geographic locations; patterns were characterized by loss of diversity and domination by single taxa. Higher diversity of intestinal microbiota at the time of neutrophil engraftment was associated with lower mortality. (Funded by the National Cancer Institute and others.)
引用
收藏
页码:822 / 834
页数:13
相关论文
共 46 条
[21]   Gut microbiome-derived metabolites modulate intestinal epithelial cell damage and mitigate graft-versus-host disease [J].
Mathewson, Nathan D. ;
Jenq, Robert ;
Mathew, Anna V. ;
Koenigsknecht, Mark ;
Hanash, Alan ;
Toubai, Tomomi ;
Oravecz-Wilson, Katherine ;
Wu, Shin-Rong ;
Sun, Yaping ;
Rossi, Corinne ;
Fujiwara, Hideaki ;
Byun, Jaeman ;
Shono, Yusuke ;
Lindemans, Caroline ;
Calafiore, Marco ;
Schmidt, Thomas C. ;
Honda, Kenya ;
Young, Vincent B. ;
Pennathur, Subramaniam ;
van den Brink, Marcel ;
Reddy, Pavan .
NATURE IMMUNOLOGY, 2016, 17 (05) :505-+
[22]   Pretreatment gut microbiome predicts chemotherapy-related bloodstream infection [J].
Montassier, Emmanuel ;
Al-Ghalith, Gabriel A. ;
Ward, Tonya ;
Corvec, Stephane ;
Gastinne, Thomas ;
Potel, Gilles ;
Moreau, Phillipe ;
de la Cochetiere, Marie France ;
Batard, Eric ;
Knights, Dan .
GENOME MEDICINE, 2016, 8
[23]   Intestinal Microbiota and Relapse After Hematopoietic-Cell Transplantation [J].
Peled, Jonathan U. ;
Devlin, Sean M. ;
Staffas, Anna ;
Lumish, Melissa ;
Khanin, Raya ;
Littmann, Eric R. ;
Ling, Lilan ;
Kosuri, Satyajit ;
Maloy, Molly ;
Slingerland, John B. ;
Ahr, Katya F. ;
Rodriguez, Kori A. Porosnicu ;
Shono, Yusuke ;
Slingerland, Ann E. ;
Docampo, Melissa D. ;
Sung, Anthony D. ;
Weber, Daniela ;
Alousi, Amin M. ;
Gyurkocza, Boglarka ;
Ponce, Doris M. ;
Barker, Juliet N. ;
Perales, Miguel-Angel ;
Giralt, Sergio A. ;
Taur, Ying ;
Pamer, Eric G. ;
Jenq, Robert R. ;
van den Brink, Marcel R. M. .
JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (15) :1650-+
[24]  
Peled JU, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.36, 10.1038/nmicrobiol.2016.36]
[25]   Variability of nutritional practices in peritransplant period after allogeneic hematopoietic stem cell transplantation: a survey by the Complications and Quality of Life Working Party of the EBMT [J].
Peric, Zinaida ;
Botti, Stefano ;
Stringer, Jacqui ;
Krawczyk, Joanna ;
van der Werf, Steffie ;
van Biezen, Anja ;
Aljurf, Mahmoud ;
Murray, John ;
Liptrott, Sarah ;
Greenfield, Diana M. ;
Duarte, Rafael F. ;
Ruutu, Tapani ;
Basak, Grzegorz W. .
BONE MARROW TRANSPLANTATION, 2018, 53 (08) :1030-1037
[26]   Antibiotic practice patterns in hematopoietic cell transplantation: A survey of blood and marrow transplant clinical trials network centers [J].
Rashidi, Armin ;
Wangjam, Tamna ;
Bhatt, Ami S. ;
Weisdorf, Daniel J. ;
Holtan, Shernan G. .
AMERICAN JOURNAL OF HEMATOLOGY, 2018, 93 (11) :E348-E350
[27]   Pretransplant Gut Colonization with Intrinsically Vancomycin-Resistant Enterococci (E. gallinarum and E. casseliflavus) and Outcomes of Allogeneic Hematopoietic Cell Transplantation [J].
Rashidi, Armin ;
Ebadi, Maryam ;
Shields-Cutler, Robin R. ;
DeFor, Todd E. ;
Al-Ghalith, Gabriel A. ;
Ferrieri, Patricia ;
Young, Jo-Anne H. ;
Dunny, Gary M. ;
Knights, Dan ;
Weisdorf, Daniel J. .
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2018, 24 (06) :1260-1263
[28]   Increased GVHD-related mortality with broad-spectrum antibiotic use after allogeneic hematopoietic stem cell transplantation in human patients and mice [J].
Shono, Yusuke ;
Docampo, Melissa D. ;
Peled, Jonathan U. ;
Perobelli, Suelen M. ;
Velardi, Enrico ;
Tsai, Jennifer J. ;
Slingerland, Ann E. ;
Smith, Odette M. ;
Young, Lauren F. ;
Gupta, Jyotsna ;
Lieberman, Sophia R. ;
Jay, Hillary V. ;
Ahr, Katya F. ;
Rodriguez, Kori A. Porosnicu ;
Xu, Ke ;
Calarfiore, Marco ;
Poeck, Hendrik ;
Caballero, Silvia ;
Devlin, Sean M. ;
Rapaport, Franck ;
Dudakov, Jarrod A. ;
Hanash, Alan M. ;
Gyurkocza, Boglarka ;
Murphy, George F. ;
Gomes, Camilla ;
Liu, Chen ;
Moss, Eli L. ;
Falconer, Shannon B. ;
Bhatt, Ami S. ;
Taur, Ying ;
Pamer, Eric G. ;
van den Brink, Marcel R. M. ;
Jenq, Robert R. .
SCIENCE TRANSLATIONAL MEDICINE, 2016, 8 (339)
[29]   Assessment of variation in microbial community amplicon sequencing by the Microbiome Quality Control (MBQC) project consortium [J].
Sinha, Rashmi ;
Abu-Ali, Galeb ;
Vogtmann, Emily ;
Fodor, Anthony A. ;
Ren, Boyu ;
Amir, Amnon ;
Schwager, Emma ;
Crabtree, Jonathan ;
Ma, Siyuan ;
Abnet, Christian C. ;
Knight, Rob ;
White, Owen ;
Huttenhower, Curtis .
NATURE BIOTECHNOLOGY, 2017, 35 (11) :1077-+
[30]   Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT [J].
Sorror, ML ;
Maris, MB ;
Storb, R ;
Baron, F ;
Sandmaier, BM ;
Maloney, DG ;
Storer, B .
BLOOD, 2005, 106 (08) :2912-2919